Breaking News Instant updates and real-time market news.

XLRN

Acceleron

$26.26

-1.23 (-4.47%)

17:01
12/22/16
12/22
17:01
12/22/16
17:01

Acceleron: First patient treated in Phase 2 ACE-083 trial

Acceleron Pharma announced that the first patient has been treated in a Phase 2 clinical trial of ACE-083, the company's locally acting muscle agent, for the treatment of patients with facioscapulohumeral muscular dystrophy. "We are excited to start our first Phase 2 trial for ACE-083," said Matthew Sherman, M.D., Chief Medical Officer of Acceleron. "ACE-083 has generated a strong data set in both preclinical and clinical trials to date. Our understanding of its novel mechanism of action suggests that ACE-083 may become an important new treatment for FSHD patients with muscle weakness that negatively affects their strength and functional abilities." The two-part Phase 2 clinical trial is designed to evaluate ACE-083 in FSHD patients with muscle weakness in either the tibialis anterior, a muscle in the lower leg involved in foot flexion, or the biceps. Part 1 is an open-label, dose-escalation study of ACE-083 administered by intramuscular injection once every three weeks in up to 36 patients to evaluate safety and increases in muscle volume over a three-month treatment period. Part 2 is a randomized, double-blind, placebo-controlled study using the optimal dose level selected in Part 1. Up to 40 patients will be randomized to receive either placebo or ACE-083 administered by intramuscular injection once every three weeks and evaluated for increases in muscle volume, strength, function and safety over a three-month treatment period.

XLRN Acceleron
$26.26

-1.23 (-4.47%)

08/19/16
08/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aratana Therapeutics (PETX) assumed with a Buy at Jefferies. 2. Arbutus Biopharma (ABUS) initiated with an Outperform at William Blair. 3. Acceleron (XLRN) initiated with a Buy at BTIG. 4. Agios Pharmaceuticals (AGIO) initiated with a Neutral at BTIG. 5. Suncor (SU) reinstated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
SBSH
09/29/16
INITIATION
Target $40
SBSH
Neutral
Acceleron initiated with a Neutral at Citi
Citi analyst Robyn Karnauskas started Acceleron Pharma with a Neutral rating and $40 price target. The company's pivotal programs are already reflected in the shares while Phase 2 catalysts could provide upside, Karnauskas tells investors in a research note.
09/29/16
SBSH
09/29/16
NO CHANGE
Target $127
SBSH
Buy
Citi ups Celgene target to $127 on luspatercept opportunity
Citi analyst Robyn Karnauskas raised her price target for Celgene (CELG) to $127 from $124 citing greater confidence in the company's myelodysplastic syndrome and beta thalassemia opportunities. After initiating coverage of Celgene partner Acceleron (XLRN) with a Neutral rating, Karnauskas now sees adjusted peak sales for these indications of $1.7B versus $825M previously. Investors are missing the "not-so-distant catalyst" as Phase 3 luspatercept data in these indications could come in late 2017/early 2018, the analyst tells investors in a research note. She keeps a Buy rating on shares of Celgene.
12/12/16
OPCO
12/12/16
INITIATION
Target $44
OPCO
Acceleron initiated with an Overweight at Oppenheimer
Oppenheimer analyst Leah Cann initiated Acceleron with an Outperform and a $44 price target saying the successful launch of two experimental products, Luspatercept and Dalantercept, could result in Acceleron having revenues grow to $367.3 million in 2021 from $18.1 million in 2015.

TODAY'S FREE FLY STORIES

PUB

People's Utah Bancorp

$27.00

0.05 (0.19%)

13:20
08/23/17
08/23
13:20
08/23/17
13:20
Hot Stocks
People's Utah Bancorp CEO sells 12,170 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$20.44

0.54 (2.71%)

13:20
08/23/17
08/23
13:20
08/23/17
13:20
Options
Second day of interest in CenturyLink September puts »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

13:17
08/23/17
08/23
13:17
08/23/17
13:17
Hot Stocks
PetMed Express tells Bloomberg Aurelius report 'false and defamatory' »

In response to an earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

$NSD

NASDAQ Market Internals

13:17
08/23/17
08/23
13:17
08/23/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$118.03

-0.25 (-0.21%)

13:16
08/23/17
08/23
13:16
08/23/17
13:16
Conference/Events
Sempra Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Aug

  • 14

    Sep

$NYE

NYSE Market Internals

13:16
08/23/17
08/23
13:16
08/23/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
08/23/17
08/23
13:15
08/23/17
13:15
General news
Jackson Hole outlook: »

Jackson Hole outlook: the…

CAVM

Cavium

$60.98

0.84 (1.40%)

13:15
08/23/17
08/23
13:15
08/23/17
13:15
Conference/Events
Cavium has a conference call hosted by William Blair »

William Blair Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 06

    Sep

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

13:12
08/23/17
08/23
13:12
08/23/17
13:12
Recommendations
PetMed Express analyst commentary  »

PetMed Express recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

SIX

Six Flags

$51.97

-1.25 (-2.35%)

, DIS

Disney

$102.04

-0.73 (-0.71%)

13:06
08/23/17
08/23
13:06
08/23/17
13:06
Hot Stocks
Six Flags Magic Mountain to launch 365-day operation on January 1 »

Six Flags Entertainment…

SIX

Six Flags

$51.97

-1.25 (-2.35%)

DIS

Disney

$102.04

-0.73 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

S

Sprint

$8.29

0.065 (0.79%)

, SSNLF

Samsung

$2,030.00

-70 (-3.33%)

13:05
08/23/17
08/23
13:05
08/23/17
13:05
Hot Stocks
Samsung Galaxy Note8 coming to Sprint for $20 a month »

Sprint (S) announced the…

S

Sprint

$8.29

0.065 (0.79%)

SSNLF

Samsung

$2,030.00

-70 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

WSM

Williams-Sonoma

$43.04

0.19 (0.44%)

13:05
08/23/17
08/23
13:05
08/23/17
13:05
Options
Williams Sonoma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

MSI

Motorola Solutions

$86.67

0.26 (0.30%)

, ZURVY

Zurich Insurance

$30.34

-0.04 (-0.13%)

13:04
08/23/17
08/23
13:04
08/23/17
13:04
Hot Stocks
Motorola Solutions names Troy Mattern as head of product cybersecurity »

Motorola Solutions (MSI)…

MSI

Motorola Solutions

$86.67

0.26 (0.30%)

ZURVY

Zurich Insurance

$30.34

-0.04 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

HPQ

HP Inc.

$18.91

-0.115 (-0.60%)

, HPE

HP Enterprise

$17.69

0.02 (0.11%)

12:56
08/23/17
08/23
12:56
08/23/17
12:56
Earnings
On The Fly: What to watch in HP Inc.'s earnings report »

HP Inc. (HPQ) is…

HPQ

HP Inc.

$18.91

-0.115 (-0.60%)

HPE

HP Enterprise

$17.69

0.02 (0.11%)

LNVGY

Lenovo

$11.13

-0.07 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 29

    Aug

  • 31

    Aug

  • 01

    Sep

  • 05

    Sep

  • 06

    Sep

BABA

Alibaba

$173.90

-0.562 (-0.32%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on Alibaba »

Alibaba mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$16.04

0.29 (1.84%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on ON Semiconductor »

ON Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Sep

KRO

Kronos Worldwide

$19.25

-0.25 (-1.28%)

12:55
08/23/17
08/23
12:55
08/23/17
12:55
Periodicals
Breaking Periodicals news story on Kronos Worldwide »

Kronos Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
08/23/17
08/23
12:55
08/23/17
12:55
General news
U.S. VIX equity volatility is up 4% near 11.82 »

U.S. VIX equity…

HCCI

Heritage-Crystal Clean

$18.15

-0.05 (-0.27%)

12:54
08/23/17
08/23
12:54
08/23/17
12:54
Periodicals
Breaking Periodicals news story on Heritage-Crystal Clean »

Heritage-Crystal Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 08

    Sep

  • 09

    Sep

12:50
08/23/17
08/23
12:50
08/23/17
12:50
General news
Breaking General news story  »

Dallas Federal Reserve…

CVM

CEL-SCI

$1.95

-0.341 (-14.89%)

12:47
08/23/17
08/23
12:47
08/23/17
12:47
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI »

Sabby Management reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$39.41

-2.32 (-5.56%)

12:46
08/23/17
08/23
12:46
08/23/17
12:46
Periodicals
PetMed Express 'exploiting' opioid epidemic in America, Aurelius Value says »

PetMed Express is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

GDDY

GoDaddy

$41.78

-0.09 (-0.21%)

12:41
08/23/17
08/23
12:41
08/23/17
12:41
Recommendations
GoDaddy analyst commentary  »

GoDaddy shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SPY

SPDR S&P 500 ETF Trust

$244.96

-0.48 (-0.20%)

12:40
08/23/17
08/23
12:40
08/23/17
12:40
Options
Sizable put spreads in SPDR 500 Trust »

Sizable put spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$92.25

0.685 (0.75%)

12:30
08/23/17
08/23
12:30
08/23/17
12:30
Options
$1.1M call sweep in JP Morgan long-term deeps »

$1.1M call sweep in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

  • 11

    Sep

  • 12

    Oct

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.